Lee S, Hamid O, Jotte R, Zakharia Y, et al. Phase 2 Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1 Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma. Clin Cancer Res 2024 Dec 30. doi: 10.1158/1078-0432.CCR-24-1478.
PMID: 39786430